Tritanium C Anterior Cervical Cage; Tritanium PL Cage; Tritanium TL Curved Posterior Lumbar Cage; Aero -C Cervical Cage System; AVS Anchor-C Cervical Cage System; AVS TL PEEK Spacer; AVS PL PEEK Spacers; AVS Navigator PEEK Spacer; AVS AS PEEK Spacer; Monterey AL Interbody System; Aleutian IBF System; Cascadia Interbody System; Chesapeake Stabilization System; Sahara Stabilization System; SANTORINI Corpectomy Cage System; MOJAVE Interbody System; VLIFT VERTEBRAL BODY REPLACEM
Stryker Spine · Decision date Jul 17, 2026
What did the FDA decide?
FDA records K262061 as a 510(k) premarket notification, with a decision dated Jul 17, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Jul 17, 2026
Regulatory record facts
- Identifier
- K262061
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Stryker Spine
- Product code
- ODP
- Decision code
- SESE
- Decision date
- Jul 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Intervertebral Fusion Device With Bone Graft, Cervical.
- Applicant
- Stryker Spine
- Product code
- ODP
- FDA device class
- 2
FDA decision timeline
K262061 received
Application receipt date recorded by FDA.
K262061 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code ODP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Wenzel Spine, Inc. | 510(k) clearance | Aug 26, 2026 | FDA | |
| L&K BIOMED CO. ,LTD. | 510(k) clearance | Aug 18, 2026 | FDA | |
3d Cage CervicalK253041 | Fims Co., Ltd. | 510(k) clearance | Jul 23, 2026 | FDA |
| C.A. Medical, LLC | 510(k) clearance | Jul 8, 2026 | FDA | |
| L&K BIOMED CO. ,LTD. | 510(k) clearance | May 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Stryker Spine
- Headquarters
- Not reported
- Brand website
- stryker.com
- FDA applicant address
- Allendale, NJ
Sources and methodology
- Original FDA record: K262061
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


